Welltower Inc.
NYSE:WELLREIT - Healthcare Facilities
+$0.44 today
- Market cap
- $181.39B
- Beta
- 0.78
- P/E (TTM)
- 102.9
- EPS (TTM)
- $2.01
- Dividend yield
- 1.43%
Volume 4.27M
Average 3.24M
WELL EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Welltower Inc.NYSE: WELL
EBITDA · Q3 FY2026 · quarter ended Sep 2026
EBITDA growth accelerates
Q3 FY2026 EBITDA of $1.29B rose 31.7% year over year, ahead of the -5.4% change in trailing-twelve-month EBITDA. Sequentially, it fell 2.9% from the prior quarter. Over 3 fiscal years it compounded at +4.2% a year.
Context
- EBITDA amounted to 21.7% of revenue in FY2025, down 13.7 pp from a year earlier.
- EBITDA increased in 2 of the last 3 fiscal years.
What to watch
Whether EBITDA reaches the consensus estimate from 5 analysts of $4.39B (+90.0%) for the fiscal year ending Dec 2026, a step up from the -16.8% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- $1.29B-2.9% QoQ
- Last fiscal yearDec 2025
- $2.31B-16.8% YoY
- LTMSep 2026
- $3.33B-5.4% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +31.7% | +415.7% | +384.0 pp |
| 1 year | -16.8% | +90.0% | +106.8 pp |
| 3-year CAGR | +4.2% | +26.1% | +21.8 pp |
| 5-year CAGR | +19.7% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 2.31B USD
- Year-over-year change
- -16.8%
- 4-year CAGR
- +7.8%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.31B | -16.8% |
| FY2024 | 2024-12-31 | 2.78B | +15.7% |
| FY2023 | 2023-12-31 | 2.4B | +17.7% |
| FY2022 | 2022-12-31 | 2.04B | +19.0% |
| FY2021 | 2021-12-31 | 1.71B | — |
EBITDA vs competitors
How WELL compares with its peers on the latest reported figures
- WELL's LTM Sep 2026 EBITDA of $3.33B is the highest of the 11 companies compared; the peer median is $725.13M.
- Its year-over-year change of -5.4% is the 10th highest of 11, against a peer median of +47.6%.
- EBITDA amounts to 24.3% of revenue for WELL, versus a peer median of 83.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $3.33B | -5.4% | +4.2% | 24.3% | |
| LTM Jun 2026 | $2.48B | +27.0% | +14.3% | 38.5% | |
| LTM Sep 2026 | $1.76B | +15.8% | +1.1% | 78.5% | |
| LTM Jun 2026 | $1.45B | +41.6% | +5.3% | 112.1% | |
MPTMedical Properties Trust, Inc. | LTM Jun 2026 | $1.05B | +979.1% | -31.2% | 103.2% |
| LTM Sep 2026 | $851.29M | +205.9% | +16.4% | 186.2% | |
| LTM Sep 2026 | $598.98M | +449.6% | +5.2% | 152.0% | |
| LTM Sep 2026 | $547.75M | +45.6% | +85.1% | 89.0% | |
| LTM Sep 2026 | $482.47M | +49.6% | +15.4% | 18.1% | |
| LTM Jun 2026 | $390.9M | -17.8% | +28.2% | 45.5% | |
NHPBPNational Healthcare Properties, Inc. | LTM Mar 2026 | $73.51M | +495.0% | +15.1% | 21.5% |
| Peer median (excluding WELL) | $725.13M | +47.6% | +14.7% | 83.8% | |
Competitors are the stored peer set for WELL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 4.71B | 5.78B | 6.48B | 7.85B | 10.67B |
| Cost of Revenue | 2.77B | 3.56B | 3.95B | 4.83B | 6.49B |
| Gross Profit | 1.93B | 2.22B | 2.53B | 3.02B | 4.18B |
| Gross Margin | 41.1% | 38.4% | 39.1% | 38.5% | 39.2% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 126.73M | 150.39M | 179.09M | 235.49M | 1.75B |
| Operating Expenses | 1.17B | 1.47B | 1.59B | 1.88B | 3.82B |
| Depreciation & Amortization | 1.05B | 1.34B | 1.44B | 1.68B | 2.14B |
| EBITDA | 1.71B | 2.04B | 2.4B | 2.78B | 2.31B |
| EBITDA Margin | 36.4% | 35.3% | 37.1% | 35.4% | 21.7% |
| Operating Income | 763.36M | 746.22M | 940.45M | 1.15B | 355.17M |
| Operating Margin | 16.2% | 12.9% | 14.5% | 14.6% | 3.3% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 489.85M | 529.52M | 607.85M | 574.26M | 651.96M |
| Other Income / Expenses | (380.16M) | (578.41M) | (575.95M) | (170.14M) | 599.55M |
| Income Before Tax | 383.19M | 167.82M | 364.5M | 975.56M | 954.72M |
| Pre-Tax Margin | 8.1% | 2.9% | 5.6% | 12.4% | 9.0% |
| Income Tax Expense | 8.71M | 7.25M | 6.36M | 2.7M | (7.12M) |
| Net Income | 336.14M | 141.21M | 340.09M | 951.68M | 936.85M |
| Net Margin | 7.1% | 2.4% | 5.2% | 12.1% | 8.8% |
| EPS (Basic) | 0.79 | 0.31 | 0.66 | 1.58 | 1.41 |
| EPS (Diluted) | 0.78 | 0.30 | 0.66 | 1.57 | 1.39 |
| Weighted Avg Shares | 424.98M | 462.19M | 515.63M | 602.98M | 665.64M |
| Weighted Avg Shares (Diluted) | 426.84M | 465.16M | 518.7M | 608.75M | 679.52M |
Welltower Inc.
NYSE:WELL
Intrinsic Alpha fair value
Locked
Current Price
$247.25
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.